EUCALIA Inc. (TYO:286A)
Japan · Delayed Price · Currency is JPY 801.00
-22.00 (-2.67%)
Sep 4, 2026, 3:30 PM JST
EUCALIA Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 27,892 | 24,734 | 19,833 | 18,054 | 16,616 | 2,891 |
Revenue Growth | 33.21% | 24.71% | 9.85% | 8.65% | 474.73% | 6.48% |
Gross Profit Gross Profit Growth | 11,044 | 10,537 | 8,691 | 7,106 | 5,809 | 1,875 |
Operating Income Operating Income Growth | 1,628 | 2,367 | 2,824 | 1,900 | 866 | 485.62 |
Net Income Net Income Growth | 2,442 | 2,776 | 2,025 | 1,051 | 980 | 564.99 |
Earnings Per Share EPS Growth | 67.66 | 76.75 | 63.12 | 35.17 | 32.79 | - |
EPS Growth | 34.15% | 21.59% | 79.49% | 7.25% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Senior Related Business Senior Related Business Growth | 9,631 | 8,894 | 6,867 | 6,653 |
Comprehensive Medical Management Support Project Comprehensive Medical Management Support Project Growth | 9,733 | 7,734 | 6,373 | 5,404 |
Highly-Managed Medical Equipment Highly-Managed Medical Equipment Growth | 4,046 | 7,456 | 6,539 | 5,961 |
Others Others Growth | 813.34 | 656.43 | 63.41 | 36.02 |
Unallocated Adjustment Unallocated Adjustment Growth | -21.36 | -6.06 | -8.67 | - |
Total Total Growth | 24,201 | 24,735 | 19,834 | 18,055 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 10,973 | 9,285 | 11,168 | 6,724 | 6,164 | 3,774 |
Total Debt Total Debt Growth | 31,087 | 29,318 | 27,215 | 26,873 | 20,502 | 13,962 |
Net Cash (Debt) Net Cash Growth | -20,114 | -20,033 | -16,047 | -20,149 | -14,338 | -10,188 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -557.25 | -553.75 | -500.01 | -674.19 | -479.75 | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 321 | -1,878 | 1,300 | - | - | - |
Capital Expenditures CapEx Growth | -780 | -921 | -1,353 | - | - | - |
Free Cash Flow Free Cash Flow Growth | -459 | -2,799 | -53 | - | - | - |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.60% | 42.60% | 43.82% | 39.36% | 34.96% | 64.85% |
Operating Margin | 5.84% | 9.57% | 14.24% | 10.52% | 5.21% | 16.80% |
Pretax Margin | 7.65% | 12.49% | 15.69% | 9.69% | 7.81% | 28.23% |
Profit Margin | 8.76% | 11.22% | 10.21% | 5.82% | 5.90% | 19.54% |
FCF Margin | -1.65% | -11.32% | -0.27% | - | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.84 | 11.90 | 16.18 | - | - | - |
Forward PE | 15.08 | 13.01 | 13.35 | - | - | - |
PS Ratio | 1.03 | 1.34 | 1.65 | - | - | - |